Find uplifting stories about heroes, innovations, and solutions
4474 results for "polycystic kidney disease"
A drug already used for diabetic kidney disease just proved it can help the other half of kidney patients too, slowing disease progression by 23%. For 674 million people living with chronic kidney disease, this could mean more time before their kidneys fail.
Congress just introduced legislation to accelerate research for polycystic kidney disease, one of America's most common genetic disorders. The move brings fresh hope to the 800,000 families watching loved ones battle this painful condition.
A new medication just became the first therapy to directly target the damaged cells causing a serious kidney disease with no approved treatments. The breakthrough offers real hope for patients with FSGS, a rare condition that often leads to kidney failure.
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
More than 14% of Americans have chronic kidney disease and don't know it, but simple blood and urine tests can catch the condition before it causes serious damage. Doctors say early detection and lifestyle changes can slow or stop this silent disease that affects every organ in the body.
A common constipation medication unexpectedly slowed kidney decline in people with chronic kidney disease by changing gut bacteria. The discovery could help millions avoid dialysis using a drug already approved and available.
Scientists have developed a one-time CRISPR treatment that fixes the genetic mutation causing the most common inherited kidney disease. Early tests show it could replace lifelong medication for 12 million people worldwide.
Mayo Clinic scientists corrected a genetic mutation causing the most common inherited kidney disease with one injection. The treatment extended survival and stopped organ damage in mice, offering hope for 12 million people worldwide.
Women with severe kidney disease are now becoming mothers after decades of doctors saying it was too dangerous. Better medical care and new research have made pregnancy safer for thousands who were told they couldn't have children.
After decades of limited options, patients with IgA nephropathy now have access to the first treatment that targets the root cause of their disease. The FDA approved sibeprenlimab in late 2025, bringing hope to thousands living with this progressive kidney condition.
After decades of limited options, five new therapies have been approved for IgA nephropathy, a kidney disease that affects millions worldwide. Doctors say this is just the beginning of a treatment revolution.
Researchers have discovered a crucial clue explaining why people with chronic kidney disease face such high rates of heart failure. This breakthrough could transform how doctors diagnose and treat two of the world's most common health conditions.
After 15 years of failed attempts, three breakthrough medications are finally stopping kidney disease progression in its tracks. Doctors now believe combining these treatments could reverse a condition affecting one in seven Americans.
Former Ghanaian MP Kojo Adu Asare defied six years of dialysis and near-death moments to receive a life-saving kidney transplant. His story is sparking urgent conversations about affordable kidney care across Ghana.
Mayo Clinic researchers discovered a promising treatment that targets harmful "zombie cells" in diabetic kidneys, potentially helping over 12 million Americans. The short-term therapy improved kidney function and reduced inflammation in groundbreaking studies.
Scientists in Newcastle are testing a groundbreaking gene therapy that could stop nephronophthisis, the top cause of kidney failure in children and young adults. Using kidney cells found in urine samples, researchers are working to fix the genetic glitch that steals healthy childhoods.
A breakthrough treatment for a devastating rare kidney condition just moved closer to reality. AstraZeneca's Ultomiris has shown encouraging results in clinical trials, offering new hope to patients with limited options.
A groundbreaking NHS study using data from 29 million people reveals how secure health monitoring can spot disease trends early and help fix care gaps. The research shows chronic kidney disease diagnoses jumped 35% above expected levels, likely due to better testing and new treatments.
A diabetes medication known for weight loss is proving to be a powerful ally for kidney and heart health. New research shows semaglutide can slow kidney disease progression and save lives.
More than 37 million Americans have chronic kidney disease, but a wave of new treatments is transforming care and giving patients healthier, fuller lives. From pregnancy support to medications that prevent kidney failure, science is rewriting what's possible.
Showing 20 of 4474